Functionally, we demonstrated that β-catenin activates or suppresses certain NF-κB-dependent cytokines and chemokines that control the tumor microenvironment and especially have been linked with preventing antitumor immunity in cancers. The gene discussed is NFKB1; the disease is cancer.